We are live on ! Find out more
KURA icon

Kura Oncology
KURA

76 hedge funds and large institutions have $299M invested in Kura Oncology in 2017 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 26 increasing their positions, 23 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

167% more first-time investments, than exits

New positions opened: 16 | Existing positions closed: 6

150% more call options, than puts

Call options by funds: $5K | Put options by funds: $2K

15% more funds holding

Funds holding: 66 → 76 (+10)

13% more repeat investments, than reductions

Existing positions increased: 26 | Existing positions reduced: 23

3% more capital invested

Capital invested by funds: $290M → $299M (+$8.64M)

0% more funds holding in top 10

Funds holding in top 10: 4 → 4 (0)

5.48% less ownership

Funds ownership: 70.13% → 64.64% (-5.5%)

Holders
76
Holders Change
+10
Holders Change %
+15.15%
% of All Funds
1.72%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.09%
New
16
Increased
26
Reduced
23
Closed
6
Calls
$5K
Puts
$2K
Net Calls
+$3K
Net Calls Change
+$3K

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$7.4M
2
GPP
Great Point Partners
Connecticut
+$6.58M
3
Morgan Stanley
Morgan Stanley
New York
+$2.97M
4
NC
Nexthera Capital
New York
+$2.76M
5
Point72 Asset Management
Point72 Asset Management
Connecticut
+$2.55M

Top Sellers

Rank Fund Capital Flow
1
PHS
PFM Health Sciences
California
-$9.72M
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$7.45M
3
Bank of Montreal
Bank of Montreal
Ontario, Canada
-$5.79M
4
Renaissance Technologies
Renaissance Technologies
New York
-$2.61M
5
Deutsche Bank
Deutsche Bank
Germany
-$2.14M
Name Holding Trade Value Shares
Change 		Change in
Stake
EC
1
EcoR1 Capital
California
$57.6M – – –
GPP
2
Great Point Partners
Connecticut
$33.6M +$6.58M +446,396 +25%
Fidelity Investments
3
Fidelity Investments
Massachusetts
$31.8M -$7.45M -505,748 -20%
PHS
4
PFM Health Sciences
California
$26.8M -$9.72M -659,428 -27%
BlackRock
5
BlackRock
New York
$23.3M +$7.4M +502,296 +49%
BI
6
BVF Inc
California
$20.7M – – –
Vanguard Group
7
Vanguard Group
Pennsylvania
$16.6M +$1.51M +102,795 +10%
BC
8
Boxer Capital
California
$12.9M – – –
CS
9
Candriam SCA
Luxembourg
$7.88M -$368K -25,000 -5%
NC
10
Nexthera Capital
New York
$6.82M +$2.76M +187,034 +72%
SCM
11
Sio Capital Management
New York
$6M +$1.71M +116,296 +42%
Millennium Management
12
Millennium Management
New York
$4.65M +$1.18M +79,989 +36%
State Street
13
State Street
Massachusetts
$4.41M +$682K +46,248 +19%
Morgan Stanley
14
Morgan Stanley
New York
$3.66M +$2.97M +201,626 +534%
Northern Trust
15
Northern Trust
Illinois
$3.59M +$364K +24,668 +12%
CCP
16
Clough Capital Partners
Massachusetts
$3.25M -$178K -12,100 -5%
Point72 Asset Management
17
Point72 Asset Management
Connecticut
$2.65M +$2.55M +173,200 New
MA
18
Minerva Advisors
Pennsylvania
$2.61M -$844K -57,300 -25%
Geode Capital Management
19
Geode Capital Management
Massachusetts
$2.55M +$48K +3,255 +2%
DCM
20
DAFNA Capital Management
California
$1.79M +$168K +11,422 +11%
EI
21
EAM Investors
California
$1.78M -$1.12M -76,300 -40%
AG
22
Artal Group
Luxembourg
$1.53M – – –
ACM
23
Alethea Capital Management
Washington
$1.37M -$324K -22,000 -20%
Renaissance Technologies
24
Renaissance Technologies
New York
$1.37M -$2.61M -177,106 -66%
BNP Paribas Financial Markets
25
BNP Paribas Financial Markets
France
$1.31M +$1.24M +84,010 +6,035%
1
2 3 4

KURA Hedge Fund Activity: Q4 2017 in Review

76 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Kura Oncology (KURA) for Q4 2017, worth a combined $299M — up 3% from $290M a quarter earlier.

Buyers outnumbered sellers: 16 funds opened new KURA positions and 6 closed out — a net gain of 10 holders — while 26 added to existing stakes and 23 trimmed.

The largest buyer was BlackRock, adding an estimated $7.4M. The largest seller was PFM Health Sciences, cutting an estimated $9.72M.

  • 76 institutional investors held Kura Oncology (KURA) as of Q4 2017, up from 66 in Q3 2017.
  • Funds reported $299M of Kura Oncology stock for Q4 2017, up 3% quarter-over-quarter.
  • 16 funds opened new Kura Oncology positions in Q4 2017 and 6 closed out, a net change of +10 holders.
  • The largest Kura Oncology buyer in Q4 2017 was BlackRock, an estimated $7.4M added.
  • The largest Kura Oncology seller in Q4 2017 was PFM Health Sciences, an estimated $9.72M sold.

Based on aggregated 13F filings for Q4 2017.